Your Path to Hope Resources

The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results were presented at the European Society for Medical Oncology Congress today by Nader Sanai, MD, Director of the Ivy Brain Tumor Center. “The Ivy Center’s Phase 0/1 study has shown a promising translation of the preclinical results of SDT in patients with glioblastoma.

Written by: Courtney Benisch – Regional Relationship Coordinator for Head for the Cure This year has been nothing but a roller coaster, and as a caregiver, I cannot even imagine what it is like watching …

It had been two months since I started a new course of chemotherapy, and I tried to imagine the damage it dealt to the tumor in my head.

Learn about a a variety of topics surrounding telehealth options for brain tumor patients.

The next post in Jenguin’s Journey covers how Jenny has had to adjust her diet during treatment.

Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador Watching TV, you’re bound to see one of those commercials for a pharmaceutical drug where they list out the side effects, and somewhere …

Dr. Khagi from UNC Neuro-Oncology Program breaks down a glioblastoma diagnosis from imaging to clinical trials to new research.

Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador No time is a good time for cancer treatment. Brain cancer interrupted my twenties with surgeries, chemotherapy and radiation therapy. When I was …

Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador Change of Plans In the brain tumor community, we “Go Gray in May” for Brain Tumor Awareness Month. I personally like the hashtag …

Preparing for Battle During a Pandemic – Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador